000 03884nam a2200385 i 4500
999 _c393144
_d393144
_x1
001 393144
003 ES-MaUEC
005 20240314174332.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 100301s2008 xxua o |||| 0|eng d
020 _a9781597452465
024 7 _a10.1007/978-1-59745-246-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aQR177
_b2008 EB
245 0 0 _aNew Antibiotic Targets
_cedited by W. Scott Champney
250 _a1st edition 2008
264 1 _aTotowa, NJ
_bHumana Press
_c2008
300 _a1 recurso en línea (XII, 274 páginas)
_b51 ilustraciones
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Medicine
_x1940-6037
_v142
505 0 _aBiocomputational Strategies for Microbial Drug Target Identification -- Methods to Assay Inhibitors of DNA Gyrase and Topoisomerase IV Activities -- A Method to Assay Inhibitors of DNA Polymerase IIIC Activity -- Methods to Identify and Characterize Inhibitors of Bacterial RNA Polymerase -- Methods to Assay Inhibitors of tRNA Synthetase Activity -- Three Methods to Assay Inhibitors of Ribosomal Subunit Assembly -- Inhibition ofChaperone-Dependent Bacterial Ribosome Biogenesis -- Assays for the Identification of Inhibitors Targeting Specific Translational Steps -- SPARK: A New Peptidyl Transferase Activity Assay -- High-Throughput Screening of Peptide Deformylase Inhibitors -- A Method to Assay Penicillin-Binding Proteins -- A Method to Assay Inhibitors of Lipopolysaccharide Synthesis -- Methods for Assessing the Structure and Function of Cationic Antimicrobial Peptides -- Flow Cytometry of Bacterial Membrane Potential and Permeability -- Bacterial Efflux Pump Inhibitors -- Mycobacterium tuberculosis ?-Ketoacyl Acyl Carrier Protein Synthase III (mtFabH) Assay: Principles and Method -- Screening for Compounds That Affect the Interaction Between Bacterial Two-Component Signal Transduction Response Regulator Protein and Cognate Promoter DNA -- The Activity of rRNA Resistance Methyltransferases Assessed by MALDI Mass Spectrometry -- Assays for ?-Lactamase Activity and Inhibition -- Studies of Enzymes That Cause Resistance to Aminoglycosides Antibiotics.
520 _aA crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies. With detailed methods and protocols for the identification and assay of these targets, "New Antibiotic Targets" provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases.
988 _aSpringer_Protocols_2008
650 7 _2embne
_9146972
_aResistencia a los medicamentos
776 0 8 _iPrinted edition:
_z9781617378430
776 0 8 _iPrinted edition:
_z9781588299154
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-59745-246-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b01/2024
_dz
_eb
_zSI